NAPSA and lung cancer: However, given Napsin A is specifically overexpressed in lung adenocarcinoma and has minimal cross-reactivity with non-lung cancers, combined Napsin A/TTF-1 staining is standard clinical practice and useful to distinguish lung adenocarcinoma36.